Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents

Obesity

Volumn 18, Issue 7, 2010, Pages 1437-1442

  Maffeis, Claudio ^a   Pinelli, Leonardo ^a   Brambilla, Paolo ^b   Banzato, Claudia ^a   Valzolgher, Laura ^a   Ulmi, Daniela ^a   Di Candia, Stefania ^c   Cammarata, Bruna ^c   Morandi, Anita ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b ASL Milano 2   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ARTICLE; BLOOD; CHILD; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; MASS SCREENING; METABOLISM; METHODOLOGY; OBESITY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PREVALENCE; PUBERTY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX RATIO; STANDARD; PREDICTIVE VALUE; PROCEDURES; STANDARDS;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MASS SCREENING; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PUBERTY; REFERENCE STANDARDS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

EID: 77954144450     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.355     Document Type: Article

References (31)

1. Nakamura Y, Saitoh S, Takagi S et al. Impact of abnormal glucose tolerance, hypertension and other risk factors on coronary artery disease. Circ J 2007;71:20-25.
2. Blake DR, Meigs JB, Muller DC et al. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 2004;53:2095-2100.
3. Tominaga M, Eguchi H, Manaka H et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999;22:920-924.
4. Qing Q, Johan E, Pekka J, Jaakko T. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow up. Diabetes Care 2003;26:2910-2914.
5. Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia 2008;51: 249-257.
6. Weiss R, Taksali SE, Tamborlane WV et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005;28:902-909. (Pubitemid 40434493)
7. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 2003;26:118-124.
8. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23:381-389.
9. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008;93:4231-4237.
10. I'Allemand D, Wiegand S, Reinehr T et al.; APV-Study Group. Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity (Silver Spring) 2008;16:1672-1679.
11. Baranowski T, Cooper DM, Harrell J et al.; STOPP-T2D Prevention Study Group. Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care 2006;29:212-217.
12. Brufani C, Ciampalini P, Grossi A et al. Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pediatr Diabetes 2009; e-pub ahead of print 30 April 2009.
13. Grandone A, Amato A, Luongo C et al. High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children. J Endocrinol Invest 2008;31:1098-1102.
14. Reinehr T, Wabitsch M, Kleber M et al. Parental diabetes, pubertal stage, and extreme obesity are the main risk factors for prediabetes in children and adolescents: a simple risk score to identify children at risk for prediabetes. Pediatr Diabetes 2008; e-pub ahead of print 18 December 2008.
15. Shalitin S, Abrahami M, Lilos P, Phillip M. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes (Lond) 2005;29:571-578.
16. Wabitsch M, Hauner H, Hertrampf M et al. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord 2004;28:307-313.
17. Love-Osborne KA, Nadeau KJ, Sheeder J, Fenton LZ, Zeitler P. Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. J Adolesc Health 2008;42:543-548.
18. Goran MI, Bergman RN, Avila Q et al. Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab 2004;89:207-212.
19. Weigensberg MJ, Ball GD, Shaibi GQ, Cruz ML, Goran MI. Decreased beta-cell function in overweight Latino children with impaired fasting glucose. Diabetes Care 2005;28:2519-2524.
20. Sinha R, Fisch G, Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-810.
21. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-1243.
22. Cacciari E, Milani S, Balsamo A et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006;29:581-593.
23. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976;51:170-179.
24. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl 4th Report):555-576.
25. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes 2006;9:512-526.
26. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
27. Akobeng AK. Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 2007;96:644-647.
28. Bock G, Dalla Man C, Campioni M et al. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 2006;55:3536-3549.
29. Marcovina S, Bowsher RR, Miller WG et al.; Insulin Standardization Workgroup. Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 2007;53: 711-716.
30. Manley SE, Stratton IM, Clark PM, Luzio SD. Comparison of 11 human insulin assays: implications for clinical investigation and research. Clin Chem 2007;53:922-932.
31. Gochman N, Ryan WT, Sterling RE, Widdowson GM. Interlaboratory comparison of enzymatic methods for serum glucose determination. Clin Chem 1975;21:356-361.